Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Nygaard

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|February 11, 2023
Intensive care unit nurses' perception of three different methods for delirium screening: A survey (DELIS-3)Anne Højager Nielsen, Laura Krone Larsen, Marie Oxenbøll Collet, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
Journal of the American Heart Association|April 26, 2022
Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown CauseJohnni Resdal Dyssekilde, Tanja Charlotte Frederiksen, Morten Krogh Christiansen, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D Solomon, John W Ostrominski, Xiaowen Wang, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
Lancet (London, England)|April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler, Sanjiv J Shah, Mark C Petrie, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|February 11, 2023
Intensive care unit nurses' perception of three different methods for delirium screening: A survey (DELIS-3)Anne Højager Nielsen, Laura Krone Larsen, Marie Oxenbøll Collet, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
Journal of the American Heart Association|April 26, 2022
Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown CauseJohnni Resdal Dyssekilde, Tanja Charlotte Frederiksen, Morten Krogh Christiansen, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott D Solomon, John W Ostrominski, Xiaowen Wang, et al.
Nature Medicine|August 27, 2023
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trialBarry A Borlaug, Dalane W Kitzman, Melanie J Davies, et al.
Lancet (London, England)|April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler, Sanjiv J Shah, Mark C Petrie, et al.
Pageof 3